Click on the links below to access the Industry Sponsored Satellite Symposia Invitations.
Friday 27 September 2019
Understanding the Emerging Role of I-O in GI Cancers
Friday, 18:00 - 20:00
View the satellite invitation
Multi-Disciplinary Perspectives on Optimising Patient Outcomes in HER2-Positive eBC
Friday, 18:00 - 20:00
View the satellite invitation
How Immuno-Oncology Has Changed the Melanoma Treatment Landscape
Friday, 18:00 - 20:00
View the satellite invitation
Long-Term Experience and Survival: An Overview of I-O Therapy in RCC and Future Research in GU Cancers
Friday, 18:00 - 20:00
View the satellite invitation
Cracking the Code of Personalised Healthcare
Friday, 18:00 - 20:00
View the satellite invitation
Putting Immunotherapy into Perspective: How Should I be Treating my SCCHN Patients?
Friday, 18:00 - 20:00
View the satellite invitation
What Potential Do TKIs Have to Optimize Outcomes in Refractory mCRC and uHCC?
Friday, 18:00 - 20:00
View the satellite invitation
From Trial Evidence to Clinical Practice: Focusing on Patients with mGC and mCRC
Friday, 18:00 - 20:00
View the satellite invitation
Integrating Precision Medicine: Are We Ready for a Paradigm Shift in Advanced Urothelial Carcinoma?
Friday, 18:00 - 20:00
View the satellite invitation
Saturday 28 September 2019
DNA Repair Deficiency as an Immunotherapy Target in Gynaecological Cancers
Saturday, 13:00 - 14:30
View the satellite invitation
Redefining Survival Expectations in Lung Cancer
Saturday, 13:00 - 14:30
View the satellite invitation
The Evolving I-O Landscape in NSCLC
Saturday, 13:00 - 14:30
View the satellite invitation
The ABCs of CDK 4/6 Inhibitors Who, When, and Why in HR-Positive/HER2-Negative MBC
Saturday, 13:00 - 14:30
View the satellite invitation
Are You Passionate about HCC? International Multidisciplinary Team Approaches to HCC Management
Saturday, 13:00 - 14:30
View the satellite invitation
Exploring Patient Cases: Challenging the Status Quo in mCRC
Saturday, 18:30 - 20:00
View the satellite invitation
Removing the Brakes on the Immune System: Gearing Up for Tumor-Promoting Inflammation Inhibitors in NSCLC
Saturday, 18:30 - 20:00
View the satellite invitation
A New Generation of Treatments for Head and Neck Cancers
Saturday, 18:30 - 20:00
View the satellite invitation
Expert Insights in Advanced ALK-Positive NSCLC Addressing Questions Faced by Physicians in Clinical Practice
Saturday, 18:30 - 20:00
View the satellite invitation
HER2-Positive Early Breast Cancer A Personalized Approach to Treatment
Saturday, 18:30 - 20:00
View the satellite invitation
Real-World Evidence and the Patient Journey: What Does the Future Hold?
Saturday, 18:30 - 20:00
View the satellite invitation
New Clinical Perspectives Of CTCS in the Era of Precision Medicine
Saturday, 18:30 - 20:00
View the satellite invitation
Sunday 29 September 2019
Expanding the Therapeutic Opportunities in Advanced Prostate Cancer
Sunday 13:00 - 14:30
View the satellite invitation
Optimizing Treatment in the Era of Precision Oncology - A Multidisciplinary Approach
Sunday, 13:00 - 14:30
View the satellite invitation
GU 2.0 - Patient Care in 2019 and Beyond
Sunday, 13:00 - 14:30
View the satellite invitation
Optimising Patient Outcomes and Quality of Life in HR+, HER2– ABC
Sunday, 13:00 - 14:30
View the satellite invitation
Making First- and Second-Line Treatment Decisions for Advanced NSCLC
Sunday, 13:00 - 14:30
View the satellite invitation
Sequencing Strategies in Metastatic Prostate Cancer: Revealing the Cards
Sunday, 18:30 - 20:00
View the satellite invitation
Personalised Approaches in Cholangiocarcinoma
Sunday, 18:30 - 20:00
View the satellite invitation
No Maintenance is Not an Option Anymore: Parp Inhibition in Ovarian Cancer
Sunday, 18:30 - 20:00
View the satellite invitation
Faster Intervention and Better Outcomes in Advanced Pancreatic Cancer Putting it into Practice
Sunday, 18:30 - 20:00
View the satellite invitation
Precision in Practice: A New Era for Oncology Treatment
Sunday, 18:30 - 20:00
View the satellite invitation
Monday 30 September 2019
From Triple-Negative to Dx-Positive Breast Cancer: Perspectives and Experience with Cancer Immunotherapy for Patients with Metastatic Triple-Negative Disease
Monday, 13:00 - 14:30
View the satellite invitation
Right Treatment, Right Time: Improving Outcomes for Patients with Advanced Lung Cancer
Monday, 13:00 - 14:30
View the satellite invitation
Evolving the Treatment Practice of Advanced EGFRm NSCLC
Monday, 13:00 - 14:30
View the satellite invitation
EGFR+, ALK+ and ROS1+ NSCLC: More Options, Right Choices
Monday, 13:00 - 14:30
View the satellite invitation
Optimising Treatment Outcomes in Patients with Advanced Braf-Mutated Melanoma
Monday, 13:00 - 14:30
View the satellite invitation
PARP Inhibitors in Ovarian Cancer Expert Perspectives on Current Clinical Questions
Monday, 13:00 - 14:30
View the satellite invitation
Quality Assurance to Optimize HER2+ Breast Cancer Treatment
Monday, 13:00 - 14:30
View the satellite invitation
Redefining Survival: Latest Advances in the Treatment of Melanoma
Monday, 18:30 - 20:00
View the satellite invitation
Defining Biomarker-Guided Immuno-Oncology Treatments
Monday, 18:30 - 20:00
View the satellite invitation
Taking the Next Step in Lung Cancer Combination Approaches with Immune Checkpoint Inhibition
Monday, 18:30 - 20:00
View the satellite invitation
The Expanding Role of Immune Checkpoint Inhibitors Across Genitourinary Cancers
Monday, 18:30 - 20:00
View the satellite invitation
Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.
View the Complete ESMO 2019 Industry Satellite Symposia Programme